Novel rearrangement reaction of a 6,14-endoethanomorphinan derivative to a benzomorphan derivative

Tetrahedron

Volumn 65, Issue 25, 2009, Pages 4808-4813

  Fujii, Hideaki ^a   Watanabe, Yoshikazu ^a   Osa, Yumiko ^a   Nemoto, Toru ^a   Sato, Noriko ^a   Nagase, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Benzomorphan; Fragmentation; Morphinan; Rearrangement

Indexed keywords

ACID ANHYDRIDE; ANALGESIC AGENT; BENZOMORPHAN DERIVATIVE; LACTONE; MORPHINAN DERIVATIVE; PENTAZOCINE; TOLUENE; TRIFLUOROMETHANESULFONIC ACID; TRIPHENYLTETRAZOLIUM;

ANALGESIC ACTIVITY; ARTICLE; DRUG SYNTHESIS; FRAGMENTATION REACTION; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 65549147627     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2009.04.055     Document Type: Article

References (39)

1. Foley K.M. In: Herz A. (Ed). Opioid II, Handbook of Experimental Pharmacology (1993), Springer, Berlin Heidelberg 711-712
2. Bryson P.D. Comprehensive in Toxicology for Emergency Clinicians. 3rd ed. (1996), Taylor & Francis, New York, NY pp 453-454
3. Gutstein H.B., and Akil H. In: Brunto L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th ed. (2006), McGraw-Hill, New York, NY 575-576
4. Xu J.Y., Fujimoto J.M., and Tseng L.F. J. Pharmacol. Exp. Ther. 263 (1992) 246
5. Fujii H., Narita M., Mizoguchi H., Murachi M., Tanaka T., Kawai K., Tseng L.F., and Nagase H. Bioorg. Med. Chem. 12 (2004) 4133
6. Fujii H., Narita M., Mizoguchi H., Hirokawa J., Kawai K., Tanaka T., Tseng L.F., and Nagase H. Bioorg. Med. Chem. Lett. 14 (2004) 4241
7. We have already reported some rearrangement reactions of morphinan derivatives.
8. Nagase H., Abe A., and Portoghese P.S. J. Org. Chem. 54 (1989) 4120
9. Fujii H., Mizusuna A., Tanimura R., and Nagase H. Heterocycles 45 (1997) 2109
10. Nagase H., Yamamoto N., Nemoto T., Yoza K., Kamiya K., Hirono S., Momen S., Izumimoto N., Hasebe K., Mochizuki H., and Fujii H. J. Org. Chem. 73 (2008) 8093
11. Watanabe, A.; Fujii, H.; Nakajima, M.; Hasebe, K.; Mochizuki, H.; Nagase, H. Bioorg. Med. Chem. Lett., 2009, 19, 2416.
12. Bentley K.W., and Ball J.C. J. Org. Chem. 23 (1958) 1720
13. Bentley K.W., Hardy D.G., and Meek B. J. Am. Chem. Soc. 89 (1967) 3293
14. Bentley K.W., Hardy D.G., Howell C.F., Fulmor W., Lancaster J.E., Brown J.J., Morton G.O., and Hardy R.A. J. Am. Chem. Soc. 89 (1967) 3303
15. Bentley K.W., Hardy D.G., Meek B., Taylor J.B., Brown J.J., and Morton G.O. J. Chem. Soc. C (1969) 2229
16. Bentley K.W., Bower J.D., and Lewis J.W. J. Chem. Soc. C (1969) 2569
17. Fragmentation of a 7-acyl-6,14-endoethenotetrahydrothebaine derivative was also reported. See Ref. 6a.
18. 7-Methylidene derivative has been prepared by other methods: Hofmann degradation of 7-dimethylaminomethyl derivative or treatment of the tosylate of the corresponding primary alcohol with t-BuOK. Bentley K.W., Hardy D.G., Lewis J.W., Readhead M.J., and Rushworth W.I. J. Chem. Soc. C (1969) 826
19. Treatment of the 7-methylidene derivative having a 6,14-etheno bridge with perchloric acid gave another product. Lewis J.W., and Readhead M.J. J. Chem. Soc. C (1972) 881 {A figure is presented}
20. Clarke E.G.C. Nature 184 (1959) 451
21. Archer S., Albertson N.F., Harris L.P., Pierson A.K., and Bird J.G. J. Med. Chem. 7 (1964) 123
22. For synthesis of pentazocine, see:
23. Kametani T., Kigasawa K., Hiiragi M., and Wagatsuma N. Heterocycles 2 (1974) 79 and references therein
24. Kametani T., Huang S., Ihara M., and Fukumoto K. Chem. Pharm. Bull. 23 (1975) 2010
25. Kametani T., Honda T., Huang S., and Fukumoto K. Can. J. Chem. 53 (1975) 3820
26. Kametani T., Huang S., Ihara M., and Fukumoto K. J. Org. Chem. 41 (1976) 2545
27. Kametani T., Kigasawa K., Hiiragi M., Wakisaka K., Uryu T., Sugi H., Saitoh S., Ishimaru H., and Haga S. Chem. Pharm. Bull. 24 (1976) 1246
28. Kametani T., Seto H., Nemoto H., and Fukumoto K. J. Org. Chem. 42 (1977) 3605
29. For synthesis of (-)-pentazocine using optical resolution, see:
30. Rice K.C., and Jacobson A.E. J. Med. Chem. 19 (1976) 430
31. Brine G.A., Berrang B., Hayes J.P., and Carroll F.I. J. Heterocycl. Chem. 27 (1990) 2139
32. Boulanger W.A. Synth. Commun. 29 (1999) 2201
33. For asymmetric synthesis of (-)-pentazocine, see:
34. Kitamura M., Hsiao Y., Ohta M., Tsukamoto M., Ohta T., Takaya H., and Noyori R. J. Org. Chem. 59 (1994) 297
35. Kitamura M., Hsiao Y., Noyori R., and Takaya H. Tetrahedron Lett. 28 (1987) 4829
36. Trost B.M., and Weiping T. J. Am. Chem. Soc. 125 (2003) 8744
37. Asymmetric synthesis of (-)-metazocine (N-methyl derivative of (-)-pentazocine) has also been reported. Meyers A.I., Dickman D.A., and Bailey T.R. J. Am. Chem. Soc. 107 (1985) 7974
38. Very recently, the asymmetric synthesis of (-)-9-epi-pentazocine was also reported. Yang X., Zhai H., and Li Z. Org. Lett. 10 (2008) 2457
39. It is known that (-)-pentazocine is more potent than its antipode. Tullar B.F., Harris L.S., Perry R.L., Pierson A.K., Soria A.E., Wetterau W.F., and Albertson N.F. J. Med. Chem. 10 (1967) 383